Bg pattern

FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet

Fexofenadine Cipla 120 mg film-coated tablets EFG

Fexofenadine hydrochloride

Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.

-Keep this leaflet, as you may need to read it again. If you have any questions, consult your doctor or pharmacist.

-This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.

-If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the Leaflet

  1. What is Fexofenadine Cipla 120 mg and what is it used for
  2. What you need to know before taking Fexofenadine Cipla
  3. How to take Fexofenadine Cipla 120 mg
  4. Possible side effects
  5. Storage of Fexofenadine Cipla 120 mg
  6. Package contents and additional information

1. What is Fexofenadine Cipla 120mg and what is it used for

Fexofenadine Cipla 120 mg contains fexofenadine hydrochloride, which is an antihistamine.

Fexofenadine Cipla 120 mg is used in adults and adolescents 12 years and older for the relief of symptoms associated with pollen allergy (seasonal allergic rhinitis) such as sneezing, runny nose, itching, and nasal congestion, as well as itchy and red eyes and tearing.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Fexofenadine Cipla 120 mg

Do not take Fexofenadine Cipla:

  • if you are allergic to fexofenadine or any of the other ingredients of this medication (listed in section 6).

Warnings and precautions

Consult your doctor, pharmacist, or nurse before taking Fexofenadine Cipla if:

  • You have liver or kidney problems.
  • You have or have had a heart condition, as this type of medication may cause an irregular or faster heartbeat.
  • You are an elderly patient.

Children and adolescents

Fexofenadine Cipla 120 mg film-coated tablets are not recommended for children and adolescents under 12 years of age.

Taking Fexofenadine Cipla with other medications

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

If you are taking apalutamide (a medication for prostate cancer), as the effect of fexofenadine may be reduced.

Indigestion products containing aluminum and magnesium may alter the action of Fexofenadine Cipla by reducing the amount of medication absorbed.

A 2-hour interval is recommended between taking Fexofenadine Cipla and the indigestion product.

Pregnancy and breastfeeding

If you are pregnant, breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Do not take Fexofenadine Cipla if you are pregnant unless it is absolutely necessary.

Fexofenadine Cipla is not recommended during breastfeeding.

Driving and using machines

Fexofenadine Cipla 120 mg tablets are unlikely to affect your ability to drive or use machines. However, make sure these tablets do not make you feel drowsy or dizzy before driving or operating machinery.

Fexofenadine Cipla contains sodium

This medication contains less than 23 mg of sodium (1 mmol) per tablet, which is essentially "sodium-free".

3. How to take Fexofenadine Cipla 120mg

Follow the exact instructions for administration of this medication as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

Adults and adolescents 12 years and older

The recommended dose is one tablet (120 mg) per day.

Take the tablet with water before a meal.

This medication starts to relieve your symptoms within 1 hour and lasts 24 hours.

Use in children and adolescents

Fexofenadine is not recommended for children and adolescents under 12 years of age.

If you take more Fexofenadine Cipla than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

The symptoms of an overdose in adults are dizziness, drowsiness, fatigue, and dry mouth.

If you forget to take Fexofenadine Cipla

Do not take a double dose to make up for forgotten doses.

Take the next dose at the scheduled time as prescribed by your doctor.

If you stop taking Fexofenadine Cipla

Consult your doctor if you want to stop taking fexofenadine before completing the treatment cycle.

If you stop taking fexofenadine before it is due, your symptoms may reappear.

If you have any further questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone gets them.

Consult your doctor immediately and stop taking Fexofenadine Cipla if you experience:

Facial swelling, lips, tongue, or throat, and difficulty breathing, as these may be signs of a severe allergic reaction.

The following side effects have also been reported:

Common side effects(may affect up to 1 in 10 people):

  • Headache
  • Drowsiness
  • Nausea
  • Dizziness

Uncommon side effects(may affect up to 1 in 100 people)

  • Fatigue
  • Drowsiness

Frequency not known (cannot be estimated from available data):

  • Difficulty sleeping (insomnia)
  • Sleep disorders
  • Nightmares
  • Nervousness
  • Fast or irregular heartbeat
  • Diarrhea
  • Hives and itching
  • Rash
  • Severe allergic reactions that may cause swelling of the face, lips, tongue, or throat, flushing, chest tightness, and difficulty breathing
  • Blurred vision

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's website: www.notificaram.es.

By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Fexofenadine Cipla 120mg

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the label/carton/blister after EXP. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package contents and additional information

Composition of Fexofenadine Cipla 120 mg

  • The active ingredient is fexofenadine hydrochloride. Each film-coated tablet contains 120 mg of fexofenadine hydrochloride.
  • The other ingredients are:
    • Core of the tablet: microcrystalline cellulose, cornstarch, sodium croscarmellose, povidone, and magnesium stearate.
    • Coating: hypromellose, titanium dioxide (E 171), macrogol, yellow iron oxide (E 172), and red iron oxide (E 172).

Appearance of the product and package contents

Fexofenadine Cipla 120 mg are film-coated tablets, peach-colored, oblong, biconvex, and smooth on both sides. Dimensions 15.00 mm x 6.5 mm.

They are packaged in PVC/PVDC/Al blisters in cartons containing 7, 10, 15, 20, 30, 50, 100, and 200 (as 10x20) tablets per package.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Cipla Europe NV, De Keyserlei 58-60, Box-19, 2018, Antwerp, Belgium

Manufacturer:

Cipla Europe NV,

De Keyserlei 58-60, Box-19, 2018, Antwerp, Belgium

or

S&D Pharma CZ, spol.s r.o,

Theodor 28, Pchery (Pharmos a.s. facility), 27308, Czech Republic

Local Representative: Cipla Europe NV, Spanish branch.

C/Guzmán el Bueno, 133, Edif Britannia, 28003, Madrid

This medication is authorized in the Member States of the European Economic Area under the following names:

Germany

Fexofenadine hydrochloride Cipla 120 mg film-coated tablets

Croatia

Fexofenadine hydrochloride Cipla 120 mg film-coated tablets

Denmark

Fexofenadine "Cipla", film-coated tablets 120 mg

Spain

Fexofenadine Cipla 120 mg film-coated tablets EFG

Finland

Fexorin

France

FEXOFENADINE CIPLA 120 mg, film-coated tablet

Hungary

Fexofenadine Cipla 120 mg film-coated tablet

Italy

Fexofenadine Cipla

Norway

Fexofenadine Cipla 120 mg film-coated tablets

Poland

Fexofenadine hydrochloride Cipla, 120 mg, film-coated tablets

Portugal

Fexofenadine hydrochloride Cipla

Sweden

Fexofenadine Cipla 120 mg film-coated tablets

Date of the last revision of this leaflet:02/2023

Online doctors for FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS

Discuss questions about FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (1056)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS?
FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS?
The active ingredient in FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS is fexofenadine. This information helps identify medicines with the same composition but different brand names.
How much does FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS is around 2.15 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS?
FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS is manufactured by Cipla Europe. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FEXOFENADINE CIPLA 120 mg FILM-COATED TABLETS?
Other medicines with the same active substance (fexofenadine) include FEXOFENADINE CIPLA 180 mg FILM-COATED TABLETS, FEXOFENADINE OPELLA 180 mg FILM-COATED TABLETS, RINIWEL 120 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media